Biocompatibles slashes Research and Development to save £4 million
This article was originally published in Clinica
Executive Summary
Biocompatibles has reduced its research and development projects from 40 to just 10 and will now concentrate on getting new products to market by the end of 1999. The UK company has funds to cover this period but says investment and disposal options will also be considered.